PCI 7 November 2023, 15:44
Temax_Krautz
Owen Mumford 12 January 2022, 17:40

Current Edition

Nasal & Pulmonary Drug Development
Staubli 11 March 2024, 13:59
Catalent: Mon 28 October 2024, 13:21
Novo Nordisk 20 March 2024, 11:21
Biosynth: Fri 4 October 2024, 10:42
Label-free Cell-based Assay for Peptide-receptor Interaction Characterisation
Clinical Research V6I2

Label-free Cell-based Assay for Peptide-receptor Interaction Characterisation

Both the drug development process and fundamental studies of mechanisms underlying biological interactions require analytical methods that mimic the in vivo situatio...
Continue Reading →
Current Perspective on TBI
Clinical Research V6I2

Current Perspective on TBI

Dr Adrian Harel of Medicortex conveys the urgency of developing mitigating therapeutics for the secondary and long-term damaging effects of TBI. His article makes cl...
Continue Reading →
Ready for Battle: How Preclinical Development Brings New Vaccines to the War on Disease
Clinical Research V6I2

Ready for Battle: How Preclinical Development Brings New Vaccines to the War on Disease

Few medical advances have made as large an impact on world health as vaccines. Yet the battle isn’t over. As new infectious diseases emerge, as old ones grow resista...
Continue Reading →
SAE Media: Fri 25 October 2024, 10:33
PHARMAP: Mon 14 October 2024, 10.36
Automa: Mon 14 October 2024, 10:22
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
Stoelzle Skyscraper: 27th November 2024
LBBOHLE, Thu 20 April 2023, 17:23
Nipro 14 March 2024, 11:35
Novonordisk: Wed 17 July 2024, 13:49